Jin Li1, Shaoqiang Lin1, Paul M Vanhoutte1, Connie W Woo2, Aimin Xu2. 1. From State Key Laboratory of Pharmaceutical Biotechnology (J.L., P.M.V., C.W.W., A.X.), Department of Medicine (J.L., A.X.), and Department of Pharmacology and Pharmacy (P.M.V., C.W.W., A.X.), University of Hong Kong, Hong Kong SAR, China; and Joint Institute of Metabolic Medicine Between State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong and Jinan University, and Central Laboratory of the First Affiliated Hospital of Jinan University, Guangzhou, China (S.L., A.X.). 2. From State Key Laboratory of Pharmaceutical Biotechnology (J.L., P.M.V., C.W.W., A.X.), Department of Medicine (J.L., A.X.), and Department of Pharmacology and Pharmacy (P.M.V., C.W.W., A.X.), University of Hong Kong, Hong Kong SAR, China; and Joint Institute of Metabolic Medicine Between State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong and Jinan University, and Central Laboratory of the First Affiliated Hospital of Jinan University, Guangzhou, China (S.L., A.X.). cwhwoo@hku.hk amxu@hku.hk.
Abstract
BACKGROUND: Altered composition of the gut microbiota is involved in both the onset and progression of obesity and diabetes mellitus. However, the link between gut microbiota and obesity-related cardiovascular complications has not been explored. The present study was designed to investigate the role of Akkermansia muciniphila, a mucin-degrading bacterium with beneficial effects on metabolism, in the pathogenesis of atherosclerosis in apolipoprotein E-deficient (Apoe(-/-)) mice. METHODS AND RESULTS: Apoe(-/-) mice on normal chow diet or a Western diet were treated with A muciniphila by daily oral gavage for 8 weeks, followed by histological evaluations of atherosclerotic lesion in aorta. Real-time polymerase chain reaction analysis demonstrated that the fecal abundance of A muciniphila was significantly reduced by Western diet. Replenishment with A muciniphila reversed Western diet-induced exacerbation of atherosclerotic lesion formation without affecting hypercholesterolemia. A muciniphila prevented Western diet-induced inflammation in both the circulation and local atherosclerotic lesion, as evidenced by reduced macrophage infiltration and expression of proinflammatory cytokines and chemokines. These changes were accompanied by a marked attenuation in metabolic endotoxemia. A muciniphila-mediated reduction in circulating endotoxin level could be attributed to the induction of intestinal expression of the tight junction proteins (zona occuldens protein-1 and occludin), thereby reversing Western diet-induced increases in gut permeability. Long-term infusion of endotoxin to Apoe(-/-) mice reversed the protective effect of A muciniphila against atherosclerosis. CONCLUSION: A muciniphila attenuates atherosclerotic lesions by ameliorating metabolic endotoxemia-induced inflammation through restoration of the gut barrier.
BACKGROUND: Altered composition of the gut microbiota is involved in both the onset and progression of obesity and diabetes mellitus. However, the link between gut microbiota and obesity-related cardiovascular complications has not been explored. The present study was designed to investigate the role of Akkermansia muciniphila, a mucin-degrading bacterium with beneficial effects on metabolism, in the pathogenesis of atherosclerosis in apolipoprotein E-deficient (Apoe(-/-)) mice. METHODS AND RESULTS:Apoe(-/-) mice on normal chow diet or a Western diet were treated with A muciniphila by daily oral gavage for 8 weeks, followed by histological evaluations of atherosclerotic lesion in aorta. Real-time polymerase chain reaction analysis demonstrated that the fecal abundance of A muciniphila was significantly reduced by Western diet. Replenishment with A muciniphila reversed Western diet-induced exacerbation of atherosclerotic lesion formation without affecting hypercholesterolemia. A muciniphila prevented Western diet-induced inflammation in both the circulation and local atherosclerotic lesion, as evidenced by reduced macrophage infiltration and expression of proinflammatory cytokines and chemokines. These changes were accompanied by a marked attenuation in metabolic endotoxemia. A muciniphila-mediated reduction in circulating endotoxin level could be attributed to the induction of intestinal expression of the tight junction proteins (zona occuldens protein-1 and occludin), thereby reversing Western diet-induced increases in gut permeability. Long-term infusion of endotoxin to Apoe(-/-) mice reversed the protective effect of A muciniphila against atherosclerosis. CONCLUSION: A muciniphila attenuates atherosclerotic lesions by ameliorating metabolic endotoxemia-induced inflammation through restoration of the gut barrier.
Authors: Paolo Marzullo; Laura Di Renzo; Gabriella Pugliese; Martina De Siena; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano Journal: Int J Obes Suppl Date: 2020-07-20
Authors: Laura E Griffin; Zora Djuric; Chris J Angiletta; Cassie M Mitchell; Mary E Baugh; Kevin P Davy; Andrew P Neilson Journal: Food Funct Date: 2019-04-02 Impact factor: 5.396
Authors: Abdellatif Bouazzaoui; Elisabeth Huber; Alexander Dan; Faisal A Al-Allaf; Jochen Pfirstinger; Günter Sprotte; Josef Köstler; Andreas Hiergeist; Andre Gessner; Wolfgang Herr; Ernst Holler Journal: Blood Date: 2016-12-23 Impact factor: 22.113
Authors: Lara Labarta-Bajo; Anna Gramalla-Schmitz; Romana R Gerner; Katelynn R Kazane; Gregory Humphrey; Tara Schwartz; Karenina Sanders; Austin Swafford; Rob Knight; Manuela Raffatellu; Elina I Zúñiga Journal: Proc Natl Acad Sci U S A Date: 2020-09-21 Impact factor: 11.205